197 related articles for article (PubMed ID: 35457134)
1. A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions Preserves the Chemical Characteristics and Biological Activity of Lyo-Secretome Isolated by Ultrafiltration.
Mareschi K; Banche Niclot AGS; Marini E; Bari E; Labanca L; Lucania G; Ferrero I; Perteghella S; Torre ML; Fagioli F
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457134
[TBL] [Abstract][Full Text] [Related]
2. A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions.
Mareschi K; Marini E; Niclot AGSB; Barone M; Pinnetta G; Adamini A; Spadea M; Labanca L; Lucania G; Ferrero I; Fagioli F
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328655
[TBL] [Abstract][Full Text] [Related]
3. Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions.
Castiglia S; Mareschi K; Labanca L; Lucania G; Leone M; Sanavio F; Castello L; Rustichelli D; Signorino E; Gunetti M; Bergallo M; Bordiga AM; Ferrero I; Fagioli F
Cytotherapy; 2014 Jun; 16(6):750-63. PubMed ID: 24529555
[TBL] [Abstract][Full Text] [Related]
4. Freeze-Dried Mesenchymal Stem Cell-Secretome Pharmaceuticalization: Optimization of Formulation and Manufacturing Process Robustness.
Mocchi M; Bari E; Marrubini G; Bonda AF; Perteghella S; Tartara F; Cofano F; Perna GD; Giovannelli L; Mandracchia D; Sorlini M; Garbossa D; Torre ML; Segale L
Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452088
[TBL] [Abstract][Full Text] [Related]
5. Influence of platelet storage time on human platelet lysates and platelet lysate-expanded mesenchymal stromal cells for bone tissue engineering.
Shanbhag S; Mohamed-Ahmed S; Lunde THF; Suliman S; Bolstad AI; Hervig T; Mustafa K
Stem Cell Res Ther; 2020 Sep; 11(1):351. PubMed ID: 32962723
[TBL] [Abstract][Full Text] [Related]
6. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
[TBL] [Abstract][Full Text] [Related]
7. Producing vesicle-free cell culture additive for human cells extracellular vesicles manufacturing.
Lorenzini B; Peltzer J; Goulinet S; Rival B; Lataillade JJ; Uzan G; Banzet S; Mauduit P
J Control Release; 2023 Mar; 355():501-514. PubMed ID: 36764527
[TBL] [Abstract][Full Text] [Related]
8. Calcium chloride declotted human platelet lysate promotes the expansion of mesenchymal stromal cells and allows manufacturing of immunomodulatory active extracellular vesicle products.
Mouloud Y; Staubach S; Stambouli O; Mokhtari S; Kutzner TJ; Zwanziger D; Hemeda H; Giebel B
Cytotherapy; 2024 Apr; ():. PubMed ID: 38819364
[TBL] [Abstract][Full Text] [Related]
9. Human Platelet Lysate Supports Efficient Expansion and Stability of Wharton's Jelly Mesenchymal Stromal Cells via Active Uptake and Release of Soluble Regenerative Factors.
Cañas-Arboleda M; Beltrán K; Medina C; Camacho B; Salguero G
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32877987
[TBL] [Abstract][Full Text] [Related]
10. Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collaborative study.
Shaz BH; Schäfer R; Fontaine MJ; Norris PJ; McKenna DH; Jin P; Reems JA; Stroncek D; Tanashi M; Marks D; Geng H; Pati S;
Cytotherapy; 2024 Jun; 26(6):531-539. PubMed ID: 38043052
[TBL] [Abstract][Full Text] [Related]
11. A proprietary GMP human platelet lysate for the expansion of dermal fibroblasts for clinical applications.
Fernández Muñoz B; Lopez-Navas L; Gonzalez Bermejo M; Lomas Romero IM; Montiel Aguilera MÁ; Campos Cuerva R; Arribas Arribas B; Nogueras S; Carmona Sánchez G; Santos González M
Platelets; 2022 Jan; 33(1):98-109. PubMed ID: 33393414
[TBL] [Abstract][Full Text] [Related]
12. Inactivated Platelet Lysate Supports the Proliferation and Immunomodulant Characteristics of Mesenchymal Stromal Cells in GMP Culture Conditions.
Mareschi K; Castiglia S; Adamini A; Rustichelli D; Marini E; Banche Niclot AGS; Bergallo M; Labanca L; Ferrero I; Fagioli F
Biomedicines; 2020 Jul; 8(7):. PubMed ID: 32708843
[TBL] [Abstract][Full Text] [Related]
13. Pilot Production of Mesenchymal Stem/Stromal Freeze-Dried Secretome for Cell-Free Regenerative Nanomedicine: A Validated GMP-Compliant Process.
Bari E; Perteghella S; Di Silvestre D; Sorlini M; Catenacci L; Sorrenti M; Marrubini G; Rossi R; Tripodo G; Mauri P; Marazzi M; Torre ML
Cells; 2018 Oct; 7(11):. PubMed ID: 30380806
[TBL] [Abstract][Full Text] [Related]
14. Four types of human platelet lysate, including one virally inactivated by solvent-detergent, can be used to propagate Wharton jelly mesenchymal stromal cells.
Chen MS; Wang TJ; Lin HC; Burnouf T
N Biotechnol; 2019 Mar; 49():151-160. PubMed ID: 30465908
[TBL] [Abstract][Full Text] [Related]
15. Human Platelet Lysate for Good Manufacturing Practice-Compliant Cell Production.
Oeller M; Laner-Plamberger S; Krisch L; Rohde E; Strunk D; Schallmoser K
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068404
[TBL] [Abstract][Full Text] [Related]
16. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum.
Ben Azouna N; Jenhani F; Regaya Z; Berraeis L; Ben Othman T; Ducrocq E; Domenech J
Stem Cell Res Ther; 2012 Feb; 3(1):6. PubMed ID: 22333342
[TBL] [Abstract][Full Text] [Related]
17. Systematic review and meta-analysis on the use of human platelet lysate for mesenchymal stem cell cultures: comparison with fetal bovine serum and considerations on the production protocol.
Palombella S; Perucca Orfei C; Castellini G; Gianola S; Lopa S; Mastrogiacomo M; Moretti M; de Girolamo L
Stem Cell Res Ther; 2022 Apr; 13(1):142. PubMed ID: 35379348
[TBL] [Abstract][Full Text] [Related]
18. Human platelet lysate supplementation of mesenchymal stromal cell delivery: issues of xenogenicity and species variability.
Allen AB; Butts EB; Copland IB; Stevens HY; Guldberg RE
J Tissue Eng Regen Med; 2017 Oct; 11(10):2876-2884. PubMed ID: 27339032
[TBL] [Abstract][Full Text] [Related]
19. Human Platelet Lysate Sustains the Osteogenic/Adipogenic Differentiation Potential of Adipose-Derived Mesenchymal Stromal Cells and Maintains Their DNA Integrity in vitro.
Shansky YD; Sergeeva NS; Sviridova IK; Karalkin PA; Kirsanova VA; Akhmedova SA; Fomicheva KA; Shkurnikov MY; Portyannikova AY; Kaprin AD
Cells Tissues Organs; 2019; 207(3-4):149-164. PubMed ID: 31593940
[TBL] [Abstract][Full Text] [Related]
20. Effects of amotosalen treatment on human platelet lysate bioactivity: A proof-of-concept study.
Christensen C; Jonsdottir-Buch SM; Sigurjonsson OE
PLoS One; 2020; 15(4):e0220163. PubMed ID: 32294080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
